Anti-NFIL3 antibody produced in rabbit
SIGMA/AV38613 - IgG fraction of antiserum
Synonym: Anti-Nuclear factor, interleukin 3 regulated
Product Type: Chemical
Immunohistochemistry Immunohistochemistry of NFIL3 in Human heart with NFIL3 antibody at 4-8 μg/mL
Immunoblotting Cell Type: transfected 293T (Cat. No. AV38613). Lanes 1. Antibody dilution (concentration) 1.25 μg/mL in cell type transfected 293T
| antibody form | IgG fraction of antiserum |
| antibody product type | primary antibodies |
| biological source | rabbit |
| clone | polyclonal |
| concentration | 0.5 mg - 1 mg/mL |
| conjugate | unconjugated |
| form | buffered aqueous solution |
| mol wt | 51 kDa |
| NCBI accession no. | NP_005375   |
| Quality Level | 100 |
| shipped in | wet ice |
| species reactivity | human |
| storage temp. | −20°C |
| target post-translational modification | unmodified |
| technique(s) | immunohistochemistry: suitable |
| western blot: suitable | |
| UniProt accession no. | Q14211 |
| Application: | Anti-NFIL3 polyclonal antibody is used to tag nuclear factor, interleukin 3 regulated for detection and quantitation by Western blotting and in plasma by immunohistochemical (IHC) techniques. It is used as a probe to determine the roles of nuclear factor, interleukin 3 regulated in haematopoietic lineages development and specialized immune function regulation. |
| Biochem/physiol Actions: | NFIL3 is a basic leucine zipper (bZIP) transcription factor that represses or activates transcription in non-osteoblastic cells. NFIL3 play a role in attenuation of PTH target gene transcription in osteoblasts. NFIL3 repression domain interacts specifically with the TBP binding repressor protein Dr1.Glucocorticoid-mediat |
| Disclaimer: | Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals. |
| General description: | Nuclear factor, interleukin 3 regulated (NFIL3, E4BP4) is a transcription factor involved in development of haematopoietic lineages. NFIL3/E4BP4 is required for development of NK cells and CD8α(+) conventional dendritic cells, and myeloid lineage commitment. NFIL3/E4BP4 also facilitates macrophage activation, polarisation of CD4(+) T cell responses and B cell class switching to IgE. |
| Immunogen: | Synthetic peptide directed towards the N terminal region of human NFIL3 |
| Physical form: | Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose. |
| Sequence: | Synthetic peptide located within the following region: MQLRKMQTVKKEQASLDASSNVDKM |
| Specificity: | Anti-NFIL3 polyclonal antibody reacts with human, bovine, and canine nuclear factor, interleukin 3 regulated proteins. |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 1 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Storage Temp. | −20°C |
| UNSPSC | 12352203 |